The first example (Simulation 3.1) in this section describes the effects of pyridostigmine on inhibition of cholinesterase, which leads to increased levels of acetylcholine in the neuromuscular junction and subsequently increases muscular activity, which is considered the PD effect in the treatment of myasthenia gravis [10, 11]. This evidence concerns the gene BCHE and myasthenia gravis.